Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Nov. 30, 2017
Nov. 30, 2016
Cash flows used in operating activities    
Net loss for the period $ (578,713) $ (400,553)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 0 27,104
Depreciation and amortization 375 372
Inventory write-off 3,546 3,424
Shares issued for services 0 43,760
Warrants issued for services 0 107,803
Change in working capital:    
Accounts and other receivables (26,630) 82,028
Inventory (13,808) (19,062)
Prepaid expenses and deposit 91,551 (2,032)
Accounts payable and accrued liabilities 27,280 898
Due to related parties (17,672) 46,621
Unearned revenue (6,250) 8,650
Net cash used in operating activities (520,321) (100,987)
Cash flows used in investing activities    
Investment in Poviva (70,000) 0
Patent (15,715) (13,684)
Net cash used in investing activities (85,715) (13,684)
Cash flows from financing activities    
Repayment of loan to a related party 0 (4,500)
Proceeds from issuance of equity 282,402 150,008
Net cash from financing activities 282,402 145,508
Increase (decrease) in cash (323,634) 30,837
Cash, beginning of period 2,533,337 93,409
Cash, end of period 2,209,703 124,246
Supplemental information of cash flows:    
Interest paid in cash 0 1,355
Subscription funds receivable 0 600,000
Common shares issued to settle accounts payable 0 17,000
Stock based compensation recognized in prepaid expenses 0 9,537
Reclassification of NCI to additional paid in capital on acquisition $ 238,476 $ 0